This protocol is judged by an institutional review board, an impartial team that reviews any clinical trials involving humans. If a research entails a Timetable I drug, after the board approves the protocol as ethical, the scientists should apply for an investigational new drug (IND) amount in the FDA.Some scientists and corporations take into acco